Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Viana Manrique"'
Autor:
Natalie C. Parra, Oliberto Sánchez, María Angélica Contreras, Rafael Maura, Alaín González, Viana Manrique-Suárez, Luis Macaya, Jorge R. Toledo
Publikováno v:
Proteins: Structure, Function, and Bioinformatics. 89:1508-1521
Tumor necrosis factor-alpha (TNF⍺) inhibitors could prevent neurological disorders systemically, but their design generally relies on molecules unable to cross the blood-brain barrier (BBB). This research was aimed to design and characterize a nove
Autor:
Raquel Montesinos, Jorge R. Toledo, Frank Camacho, Luis Macaya, Oliberto Sánchez, Alaín González, María Angélica Contreras, Viana Manrique
Publikováno v:
Proteins: Structure, Function, and Bioinformatics. 89:1557-1564
The neutralization of tumor necrosis factor alpha (TNFα) with biopharmaceuticals is a successful therapy for inflammatory diseases. Currently, one of the main TNFα-antagonists is Etanercept, a dimeric TNF-R2 ectodomain. Considering that TNFα and i
Autor:
Humberto Nicolini, Nuria Lanzagorta, Viana Manrique, Brenda Cabrera-Mendoza, Maria A. Bobes, Lilia López-Cánovas, Alma Delia Genis-Mendoza, Daniel Santana
Publikováno v:
Redalyc
Introduction. It has been hypothesized that pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS) etiology results from an abnormal immune response to streptococcal infection. There is evidence that the sero
Autor:
null Viana Manrique‐Suárez, null Luis Macaya, null Maria Angélica Contreras, null Natalie Parra, null Rafael Maura, null Alaín González Pose, null Jorge R. Toledo, null Oliberto Sánchez
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd9305287a1940a9576958c9c309dc7e
https://doi.org/10.1002/prot.26173/v2/response1
https://doi.org/10.1002/prot.26173/v2/response1
Autor:
Verónica Avello, Santiago Salazar, Eddy E. González, Paula Campos, Viana Manríque, Christian Mathieu, Florence Hugues, Ignacio Cabezas, Paula Gädicke, Natalie C. Parra, Jannel Acosta, Oliberto Sánchez, Alaín González, Raquel Montesino
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 16, p 8734 (2024)
Multivalent live-attenuated or inactivated vaccines are often used to control the bovine viral diarrhea disease (BVD). Still, they retain inherent disadvantages and do not provide the expected protection. This study developed a new vaccine prototype,
Externí odkaz:
https://doaj.org/article/62e163f406a84b6fb35e0c3c4af97b6c
Publikováno v:
Current pharmaceutical biotechnology. 22(11)
The main obstacle to biopharmaceutical delivery in therapeutic concentration into the brain for treating neurological disorders is the presence of the Blood-Brain Barrier (BBB). The physiological process of Receptor-Mediated Transcytosis (RMT) to tra
Publikováno v:
BMC Proceedings. 14
Autor:
Viana Manrique Suárez, Nelson Santiago Vispo, Parra Pereira Natalie Carolina, Luis Macaya Zapata, Rafael Maura Pérez, Oliberto Sánchez Ramos
Publikováno v:
Alzheimer's & Dementia. 15
Autor:
Gerardo Escalona Venegas, Esperanza Niubo, Berenice Parra, Ana María Riverón, Israel Miranda Lopez, Julián Pérez Amarillo, Margarita Valdes-Dapena, Yaumara López, Lilia López-Cánovas, Viana Manrique
Publikováno v:
The Journal of Infection in Developing Countries. 9:710-719
Introduction: Group A streptococci (GAS) is responsible of several human diseases ranging from mild infection to severe invasive toxin-mediated disease and post-infectious sequelae. Accordingly, a GAS surveillance program based on molecular technique
Autor:
Maria A. Bobes, David Higginson Clarke, Ana María Riverón, Elena del Carmen Ruiz López, Viana Manrique Suárez, Yuriem Fernandez, Lilia López-Cánovas
Publikováno v:
American Journal of Alzheimer's Disease & Other Dementiasr. 29:236-241
Background: Apolipoprotein E (ApoE) ∊4 genotype is the most clearly documented risk factor for Alzheimer’s disease (AD). Epidemiological studies demonstrate an accelerated rate of progression to dementia and AD in patients with mild cognitive imp